NEXGEN is a Horizon Europe Research and Innovation Project aiming to revolutionise the treatment and diagnosis of Parkinson's. NEXGEN pioneers a new vaccine platform which produces substantially stronger immune responses than any existing vaccines, and develops a new diagnostic assay to detect biomarkers of Parkinson's in blood and urine for earlier detection. Combined together, NEXGEN marks the beginning of a new generation of solutions for Parkinson's and other non communicable diseases, substantially improving the lives of millions. See our About page for more details about what is so special about the vaccines and diagnostic assays developed in NEXGEN and what activities are taking place during the project.